Olr119 inhibitors are a class of chemical compounds specifically designed to target and modulate the activity of the Olr119 receptor, a member of the olfactory receptor family. These receptors are part of the G protein-coupled receptor (GPCR) superfamily, which play crucial roles in detecting and responding to various chemical signals. Olr119 inhibitors function by binding to the receptor's active site or allosteric sites, thereby preventing the receptor from interacting with its natural ligands or other activating molecules. This inhibition can alter the receptor's conformation, blocking the downstream signaling pathways typically initiated by ligand binding. The design of Olr119 inhibitors often involves detailed knowledge of the receptor's three-dimensional structure, which can be obtained through techniques like computational modeling, X-ray crystallography, or cryo-electron microscopy. These structural insights allow chemists to create inhibitors with high specificity and affinity, ensuring that they effectively target the Olr119 receptor without interacting with other similar receptors.
Chemically, Olr119 inhibitors can vary widely in their structure, size, and physicochemical properties. Some inhibitors are small molecules with a high degree of lipophilicity, enabling them to easily penetrate cell membranes and reach their target receptors within cellular environments. Others may be larger, more complex molecules that require specific delivery mechanisms or modifications to enhance their stability and solubility. The synthesis of Olr119 inhibitors often involves multiple steps of organic synthesis, including the formation of key functional groups that are critical for binding to the receptor. Additionally, the inhibitors must be carefully characterized using techniques such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry, and high-performance liquid chromatography (HPLC) to ensure their purity and confirm their inhibitory activity. The study and development of Olr119 inhibitors provide valuable insights into the function of olfactory receptors and the broader mechanisms by which these receptors mediate sensory perception. Understanding these interactions at a molecular level can lead to further advancements in the field of chemical biology and receptor research.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
BYL719 | 1217486-61-7 | sc-391001 sc-391001A sc-391001B sc-391001C sc-391001D sc-391001E | 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $383.00 $585.00 $740.00 $1169.00 $4902.00 $9186.00 | 2 | |
PI3K inhibitor, potentially disrupts signaling pathways that Olr119 might be involved in, altering its activity. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $153.00 $561.00 | ||
HDAC inhibitor, could alter chromatin structure and gene expression, affecting Olr119. | ||||||
5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine | 1032900-25-6 | sc-505041 | 1 mg | $230.00 | ||
ALK inhibitor, might affect signaling pathways Olr119 is involved in, thereby influencing its function. | ||||||
Lenvatinib | 417716-92-8 | sc-488530 sc-488530A sc-488530B | 5 mg 25 mg 100 mg | $178.00 $648.00 $1657.00 | 3 | |
Multi-kinase inhibitor, could impact angiogenesis and signaling pathways related to Olr119. | ||||||
Niraparib | 1038915-60-4 | sc-507492 | 10 mg | $150.00 | ||
PARP inhibitor, might affect DNA repair pathways, potentially influencing Olr119. | ||||||
Osimertinib | 1421373-65-0 | sc-507355 | 5 mg | $86.00 | ||
EGFR inhibitor, could disrupt pathways Olr119 might be involved in, modifying its activity. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $315.00 | ||
CDK4/6 inhibitor, can affect cell cycle regulation pathways involving Olr119. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $246.00 $490.00 $536.00 | 16 | |
JAK inhibitor, might alter cytokine signaling, potentially affecting Olr119's activity. | ||||||
ABT-199 | 1257044-40-8 | sc-472284 sc-472284A sc-472284B sc-472284C sc-472284D | 1 mg 5 mg 10 mg 100 mg 3 g | $116.00 $330.00 $510.00 $816.00 $1632.00 | 10 | |
BCL-2 inhibitor, can modulate apoptosis pathways potentially linked to Olr119 function. | ||||||